Abstract
High expression of VEGFC predicts adverse prognosis in acute myeloid leukemia (AML). We therefore explored VEGFC-targeting efficacy as an AML therapy ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
